Drug Shortage Report for RECOMBIVAX HB

Last updated on 2017-10-12 History
Report ID 15524
Drug Identification Number 02243676
Brand name RECOMBIVAX HB -(PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5MCG/0.5ML 1DOSE VIAL (Ped)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-08-02
Actual start date 2017-08-02
Estimated end date 2017-09-18
Actual end date 2017-08-24
Shortage status Resolved
Updated date 2017-10-12
Company comments Limited Quantities available / Quantités limitées disponibles
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2017-10-12 English Compare
v12 2017-08-25 French Compare
v11 2017-08-25 English Compare
v10 2017-08-15 English Compare
v9 2017-08-03 English Compare
v8 2017-08-02 English Compare
v7 2017-08-02 English Compare
v6 2017-08-02 English Compare
v5 2017-08-02 English Compare
v4 2017-08-02 English Compare
v3 2017-08-02 English Compare
v2 2017-07-12 French Compare
v1 2017-07-12 English Compare